In summary, interruption of CIH exposure and AAV9-PHD3 treatment can delay the cardiac remodeling and left ventricular systolic dysfunction induced by CIH exposure but cannot alter the cardiac remodeling and left ventricular systolic dysfunction induced by TAC. This evidence concerns the gene EGLN3 and persistent truncus arteriosus.